GPNX
NOTIFICATION PROCESSED BY IB
11/20/2022
Back to search
Official data from USPTO
ADVIRIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ADVIRIN
ST13
US500000079326204Class
5, 42, 44
Filing
79326204
Registration
6854765
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
11/20/2022
Classification
Registered
Trademark type
Word
Nice classes
5, 42, 44
Filing date
09/03/2021
Registration date
09/27/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/27/2022
Last transaction
09/27/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
DE
Examiner
WERT, KARL
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
AdVita Lifescience GmbH
Representatives
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals for the treatment of lung diseases; medicines used to treat lung diseases by inhalation
Class 42
Research and development of new products for others in the field of respiratory diseases; research and development services in the field of respiratory diseases
Class 44
Medical servicesconducting medical tests for diagnosis and treatment in the field of respiratory diseases
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/01/2022
FIMP
FINAL DISPOSITION PROCESSED
11/01/2022
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
10/27/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/27/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/27/2022
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
08/10/2022
GPNX
NOTIFICATION PROCESSED BY IB
07/19/2022
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
07/16/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/12/2022
PUBO
PUBLISHED FOR OPPOSITION
07/12/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/29/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/29/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/22/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/09/2022
DOCK
ASSIGNED TO EXAMINER
06/09/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/12/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/09/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/09/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/09/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/23/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/19/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/18/2021
Continuous trademark protection
Get notified about every new filing that threatens ADVIRIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.